Business
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
RNS System featured in over 50 Scientific Presentations and Posters MOUNTAIN VIEW, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a
About this update from Neuropace, Inc.
[{"type":"text","content":"RNS System featured in over 50 Scientific Presentations and Posters\nMOUNTAIN VIEW, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will have a substantial presence at the 77th American Epilepsy Society Annual Meeting (AES 2023), to be held in Orlando, Florida and virtually from December 1-5, 2023. “The Society’s annual meeting is the largest conference in the field of epilepsy in the U.S.,” said Martha Morrell, M.D., NeuroPace’s Chief Medical Officer. “We look forward to collaborating with the many healthcare providers, scientists, and others from all over the world who are gathering in Orlando to promote better outcomes for people with epilepsy. We will host various presentations and events highlighting our RNS System and look forward to engaging with the broader scientific community in the epilepsy field.” Over 50 original scientific presentations and posters regarding the RNS System will be presented throughout the meeting, as well as a number of general meeting sessions that include how the RNS System provides an important therapy option for the treatment of drug resistant epilepsy. These presentations, posters, and events involve key opinion leaders as well as early career scientists and clinicians, all of whom aim to improve the lives of patients living with drug-resistant epilepsy. Presentation & Event Details: Fellows Networking Reception: Practical Advice for Building an Advanced Neuromodulation Practice Post-Fellowship Date/Time: December 1, 2023, from 6:30pm-8:30pm ET Product Theater: How Responsive Neuromodulation is Informing Future Epilepsy Treatment Applying Responsive Neuromodulation for Generalized Epilepsies: Breakthrough RCT in IGE Treatment and Exploration of LGSDate/Time: December 2, 2023, from 2:30pm-3:00pm ET Location: Product Theater, Exhibit Hall, Orange County Convention Center Exploiting the iEEG: Future Artificial Intelligence Applications to Revolutionize Neuromodulation Date/Time: December 2, 2023, from 3:00pm-3:30pm ET Location: Product Theater, Exhibit Hall, Orange County Convention Center NeuroPace will also host several dinner sessions on topics such as using SEEG to inform corticothalamic neuromodulation and providing the RNS Sys...